Skip to main content

Articles

Page 48 of 90

  1. Cystatin C (Cys C) used clinically for detecting early acute kidney injury (AKI) was reported to be associated with thyroid function. Therefore, whether the performance of Cys C is affected by thyroid hormones...

    Authors: Danqing Zhang, Lu Gao, Heng Ye, Ruibin Chi, Lin Wang, Linhui Hu, Xin Ouyang, Yating Hou, Yujun Deng, Yi Long, Weiping Xiong and Chunbo Chen
    Citation: BMC Nephrology 2019 20:41
  2. Nephron-sparing surgery (NSS) remains gold standard for the treatment of localised renal cell cancer (RCC), even in case of a normal contralateral kidney. Compared to radical nephrectomy, kidney failure and ca...

    Authors: Jan Ebbing, Felix Menzel, Paolo Frumento, Kurt Miller, Bernhard Ralla, Tom Florian Fuller, Jonas Busch, Justin William Collins, Christofer Adding, Hans Helge Seifert, Peter Ardelt, Christian Wetterauer, Timm Westhoff and Carsten Kempkensteffen
    Citation: BMC Nephrology 2019 20:40

    The Correction to this article has been published in BMC Nephrology 2019 20:86

  3. The problem of organ shortage is an important issue in kidney transplantation, but the effect of kidney donation on AKI is unclear. The aim of this study was to investigate the impact of acute kidney injury (A...

    Authors: Woo Yeong Park, Min-Seok Choi, Young Soo Kim, Bum Soon Choi, Cheol Whee Park, Chul Woo Yang, Yong-Soo Kim, Kyubok Jin, Seungyeup Han and Byung Ha Chung
    Citation: BMC Nephrology 2019 20:39
  4. Older people with advanced kidney disease require information and support from clinicians when deciding whether to have dialysis or conservative (non-dialysis) care. There is evidence that communication practi...

    Authors: Lucy Ellen Selman, Katherine Bristowe, Irene J. Higginson and Fliss E. M. Murtagh
    Citation: BMC Nephrology 2019 20:38
  5. Hyperphosphataemia in dialysis subjects is associated with increased mortality. However cause and effect has not been proven, and the ideal phosphate target range is unknown despite KDOQI’s call for studies ov...

    Authors: Ramya Bhargava, Philip A. Kalra, Mark Hann, Paul Brenchley, Helen Hurst and Alastair J. Hutchison
    Citation: BMC Nephrology 2019 20:37
  6. Only a few prospective trials exist regarding the use of novel direct-acting antiviral agents (DAAs) in kidney transplant recipients (KTR) with chronic hepatitis C virus (HCV) infection.

    Authors: Michael Duerr, Eva V. Schrezenmeier, Lukas J. Lehner, Léon Bergfeld, Petra Glander, Stephan R. Marticorena Garcia, Christian E. Althoff, Ingolf Sack, Susanne Brakemeier, Kai-Uwe Eckardt, Klemens Budde and Fabian Halleck
    Citation: BMC Nephrology 2019 20:36
  7. Innovative care models such as public-private partnerships (PPPs) may help meet the challenge of providing cost-effective high-quality care for the steadily growing and complex chronic kidney disease populatio...

    Authors: L. A. Pedrini, A. C. Winter, F. Cerino, A. M. Zawada, M. Garbelli, A. Feuersenger, A. Feliciani, P. Ruggiero, S. Civardi, C. Amato, B. Canaud, S. Stuard, A. Karch and A. Gauly
    Citation: BMC Nephrology 2019 20:35
  8. Globally, there is increased clinical interest and uptake of hemodiafiltration (HDF) for increased removal of uremic toxins. To date, there has been no epidemiological analysis of HDF in China. We present HDF ...

    Authors: Weiming Zhang, Changlin Mei, Nan Chen, Xiaoqiang Ding, Zhaohui Ni, Chuanming Hao, Jinghong Zhang, Jinyuan Zhang, Niansong Wang, Gengru Jiang, Zhiyong Guo, Chen Yu, Yueyi Deng, Haiming Li, Qiang Yao, Mark R. Marshall…
    Citation: BMC Nephrology 2019 20:34
  9. An increasing amount of evidence has demonstrated an association between an increase in the level of tumor necrosis factor superfamily 13 (TNFSF13) and immunoglobulin A nephropathy (IgAN) progression. We aimed...

    Authors: Hyung Ah Jo, Seung Seok Han, Sunhwa Lee, Joo Young Kim, Seung Hee Yang, Hajeong Lee, Jae Seok Yang, Jung Pyo Lee, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim, Curie Ahn, Jin Suk Han and Dong Ki Kim
    Citation: BMC Nephrology 2019 20:33
  10. Electronic health records (EHR) detect the onset of acute kidney injury (AKI) in hospitalized patients, and may identify those at highest risk of mortality and renal replacement therapy (RRT), for earlier targ...

    Authors: Sanmay Low, Anantharaman Vathsala, Tanusya Murali Murali, Long Pang, Graeme MacLaren, Wan-Ying Ng, Sabrina Haroon, Amartya Mukhopadhyay, Shir-Lynn Lim, Bee-Hong Tan, Titus Lau and Horng-Ruey Chua
    Citation: BMC Nephrology 2019 20:32
  11. People with chronic kidney disease (CKD) are at an increased risk of developing hyperkalaemia due to their declining kidney function. In addition, these patients are often required to reduce or discontinue gui...

    Authors: Marc Evans, Eirini Palaka, Hans Furuland, Hayley Bennett, Cecilia Linde, Lei Qin, Phil McEwan and Ameet Bakhai
    Citation: BMC Nephrology 2019 20:31
  12. Only few studies of living kidney donors have included controls that were similarly healthy, including excellent kidney function.

    Authors: Ayelet Grupper, Yoel Angel, Aharon Baruch, Idit F. Schwartz, Doron Schwartz, Richard Nakache, Yaacov Goykhman, Paulina Katz, Ido Nachmany, Nir Lubezky, Talia Weinstein, Moshe Shashar, Orit Kliuk Ben-Bassat, Shlomo Berliner, Ori Rogowski, David Zeltser…
    Citation: BMC Nephrology 2019 20:30
  13. Anti-glomerular basement membrane (anti-GBM) disease is characterized by circulating IgG glomerular basement membrane antibodies and is clinically expressed as a rapidly progressive crescentic glomerulonephrit...

    Authors: Barbora Sporinova, Susanna A. McRae, Daniel A. Muruve, Marvin J. Fritzler, Samih H. Nasr, Alex C. Chin and Hallgrimur Benediktsson
    Citation: BMC Nephrology 2019 20:29
  14. Data on radial access (RA) as an independent risk factor for acute kidney injury (AKI) in myocardial infarction (MI) patients are conflicting. Our aim was to assess how RA influences the incidence of AKI in MI...

    Authors: Vojko Kanic, Gregor Kompara, David Šuran, Alojz Tapajner, Franjo Husam Naji and Andreja Sinkovic
    Citation: BMC Nephrology 2019 20:28
  15. Hemophagocytic lymphohistiocytosis (HLH) is characterized by excessive activation of the immune system due to infection, autoimmune diseases, or malignancy. As an aggressive and life-threatening clinical syndr...

    Authors: Bixia Gao, Xiaoyu Jia, Jicheng Lv and Jie Dong
    Citation: BMC Nephrology 2019 20:27
  16. Garlic can be considered as a useful natural herb in inhibition of inflammation. The aim of this study was to assess the effectiveness of garlic extract in lowering inflammatory markers in peritoneal dialysis ...

    Authors: Elham Zare, Amirhesam Alirezaei, Mahmood Bakhtiyari and Asieh Mansouri
    Citation: BMC Nephrology 2019 20:26
  17. Anti-glomerular basement membrane (GBM) glomerulonephritis does not usually coexist with another glomerulonephritis such as IgA nephropathy. We present a rare case having a combination of these two diseases, a...

    Authors: Tadasu Kojima, Go Hirose, Shuuhei Komatsu, Taito Oshima, Kentaro Sugisaki, Tomohiro Tomiyasu, Noriko Yoshikawa, Muneharu Yamada and Takashi Oda
    Citation: BMC Nephrology 2019 20:25
  18. Reproductive function in women with end stage renal disease generally improves after kidney transplant. However, pregnancy remains challenging due to the risk of adverse clinical outcomes.

    Authors: Silvi Shah, Renganathan Lalgudi Venkatesan, Ayank Gupta, Maitrik K. Sanghavi, Jeffrey Welge, Richard Johansen, Emily B. Kean, Taranpreet Kaur, Anu Gupta, Tiffany J. Grant and Prasoon Verma
    Citation: BMC Nephrology 2019 20:24
  19. Understanding the uncommon association of IgG4-related disease with other disorders is essential for the accurate diagnosis and effective treatment of patients. To the best of our knowledge, there have been on...

    Authors: Shen-Ju Gou, Lu-Jia Xue and Zhang-Xue Hu
    Citation: BMC Nephrology 2019 20:23
  20. After two-years of follow-up of 263 apparently healthy 18- to 30-year-old men in communities affected by Mesoamerican nephropathy (MeN), we identified three distinct case groups: a subgroup with (i) establishe...

    Authors: Marvin Gonzalez-Quiroz, Evangelia-Theano Smpokou, Neil Pearce, Ben Caplin and Dorothea Nitsch
    Citation: BMC Nephrology 2019 20:21
  21. We report a 61-year-old female with end-stage renal disease (ESRD) secondary to polycystic kidney disease (PKD) complicated by intradialytic hypertension (IDH). Increased sympathetic drive leading to increased...

    Authors: Zachary Wolfmueller, Kunal Goyal and Bhanu Prasad
    Citation: BMC Nephrology 2019 20:19
  22. Recent researches indicate that the intestinal consequences of renal ischemia reperfusion (IR) would predispose to the translocation of gut-derived endotoxin. Here, we designed experiments to test the hypothes...

    Authors: Jiangtao Li, Krishna Rekha Moturi, Lirui Wang, Kun Zhang and Chen Yu
    Citation: BMC Nephrology 2019 20:16
  23. The case report is to evaluate the efficacy and safety of embolization of a high-output idiopathic renal arteriovenous fistula (IRAVF) with an atrial septal defect occluder (ASDO) via venous access.

    Authors: Xiaomao Chen, Qingle Zeng, Peng Ye, Hongfei Miao and Yong Chen
    Citation: BMC Nephrology 2019 20:15
  24. It is well known that vascular endothelial growth factor (VEGF) inhibitors can cause proteinuria. The incidence of proteinuria is high for bevacizumab, a humanized monoclonal antibody directed against VEGF, bu...

    Authors: Ryo Yamada, Takao Okawa, Ken Matsuo, Makoto Suzuki, Noriko Mori and Kiyoshi Mori
    Citation: BMC Nephrology 2019 20:14
  25. Iron deficiency is frequent in haemodialysis (HD) patients with chronic kidney disease (CKD), and intravenous iron is an established therapy for these patients. This study assessed treatment routine, effective...

    Authors: Ashraf I. Mikhail, Staffan Schön, Sylvia Simon, Christopher Brown, Jörgen B. A. Hegbrant, Gert Jensen, Jason Moore and Lennart D. I. Lundberg
    Citation: BMC Nephrology 2019 20:13
  26. The use of HbA1c ≥6.5% for diagnosis of diabetes has been challenged for post-transplantation diabetes mellitus (PTDM) also known as new onset diabetes after transplantation (NODAT) due to a low sensitivity ea...

    Authors: Amin M. Ussif, Anders Åsberg, Thea Anine Strøm Halden, Espen Nordheim, Anders Hartmann and Trond Jenssen
    Citation: BMC Nephrology 2019 20:12
  27. Use of routine medical care (RMC) is advocated to address ethnic/racial disparities in chronic kidney disease (CKD) risks, but use is less frequent among African Americans. Factors associated with low RMC use ...

    Authors: Clarissa J. Diamantidis, Clemontina A. Davenport, Joseph Lunyera, Nrupen Bhavsar, Julia Scialla, Rasheeda Hall, Crystal Tyson, Mario Sims, Tara Strigo, Neil R. Powe and L. Ebony Boulware
    Citation: BMC Nephrology 2019 20:11
  28. There is a paucity of specific data on early stages of chronic kidney disease (CKD) among Asian Americans (AAs). The objective of this study was to examine the independent association of Asian race/ethnicity a...

    Authors: Merle Kataoka-Yahiro, James Davis, Krupa Gandhi, Connie M. Rhee and Victoria Page
    Citation: BMC Nephrology 2019 20:10
  29. Experimental studies have shown that exposure to incense burning may have deleterious effects on kidney function and architecture. However, the association between chronic exposure to incense smoke and risk of...

    Authors: Ting-Ting Geng, Tazeen Hasan Jafar, Jian-Min Yuan and Woon-Puay Koh
    Citation: BMC Nephrology 2019 20:9
  30. Most people who make the transition to renal replacement therapy (RRT) are treated with a fixed dose thrice-weekly hemodialysis réegimen, without considering their residual kidney function (RKF). Recent papers...

    Authors: Javier Deira, Miguel A. Suárez, Francisca López, Emilio García-Cabrera, Antonio Gascón, Eduardo Torregrosa, Giannina E. García, Jorge Huertas, Jose C. de la Flor, Suleya Puello, Jonathan Gómez-Raja, Jesús Grande, José L. Lerma, Carlos Corradino, Carlos Musso, Manuel Ramos…
    Citation: BMC Nephrology 2019 20:8
  31. Health-related quality of life (HrQoL) varies among dialysis patients. However, little is known about the association of dialysis modality with HrQoL over time. We describe longitudinal patterns of HrQoL among...

    Authors: Nwamaka D. Eneanya, Dugan W. Maddux, Marta M. Reviriego-Mendoza, John W. Larkin, Len A. Usvyat, Frank M. van der Sande, Jeroen P. Kooman and Franklin W. Maddux
    Citation: BMC Nephrology 2019 20:7
  32. Goodpasture Syndrome (GS) is an autoimmune disease caused by the development of auto-antibodies against the Glomerular Basement Membrane (GBM). Linear deposit of immunoglobulins G on the GBM detected by immuno...

    Authors: V. Thibaud, N. Rioux-Leclercq, C. Vigneau and S. Morice
    Citation: BMC Nephrology 2019 20:6
  33. The optimal treatment algorithm for iron therapy and the use of erythropoiesis-stimulating agents (ESA) in anemic hemodialysis (HD) patients has not been established. Hemoglobin (Hb) target levels can be achie...

    Authors: Maciej Drozdz, André Weigert, Fatima Silva, João Frazão, Abdulkareem Alsuwaida, Mahesh Krishnan, Werner Kleophas, Szymon Brzosko, Fredrik K. Johansson and Stefan H. Jacobson
    Citation: BMC Nephrology 2019 20:5
  34. HIV-positive persons bear an excess burden of chronic kidney disease (CKD); however, conventional methods to assess kidney health are insensitive and non-specific for detecting early kidney injury. Urinary bio...

    Authors: Anthony N. Muiru, Michael G. Shlipak, Rebecca Scherzer, William R. Zhang, Simon B. Ascher, Vasantha Jotwani, Carl Grunfeld, Chirag R. Parikh, Derek Ng, Frank J. Palella Jr, Ken Ho, Seble Kassaye, Anjali Sharma, Mardge Cohen, Ruibin Wang, Qibin Qi…
    Citation: BMC Nephrology 2019 20:4
  35. Electronic health record (EHR) data is increasingly used to identify patients with chronic kidney disease (CKD). EHR queries used to capture CKD status, identify comorbid conditions, measure awareness by provi...

    Authors: Martin Frigaard, Anna Rubinsky, Lo Lowell, Anna Malkina, Leah Karliner, Michael Kohn and Carmen A Peralta
    Citation: BMC Nephrology 2019 20:3
  36. This cluster randomised controlled trial set out to investigate the feasibility and acceptability of the “Combined Diabetes and Renal Control Trial” (C-DIRECT) intervention, a nurse-led intervention based on m...

    Authors: K. Griva, M. Rajeswari, M. Nandakumar, E. Y. H. Khoo, V. Y. W. Lee, C. G. Chua, Z. S. Goh, Y. T. D. Choong and S. P. Newman
    Citation: BMC Nephrology 2019 20:2
  37. Drug-induced nephrotic syndrome (NS) can be resolved by eliminating the causative agents. However, patients with metastatic cancer have not been previously reported to achieve complete recovery from anticancer...

    Authors: So-Yeon Jeon, Na-Ri Lee and Chang-Yeol Yim
    Citation: BMC Nephrology 2019 20:1
  38. Most studies on obesity surgery have measured renal function using the estimated GFR. However, due to the reduction of muscle mass, and therefore creatinine that accompanies weight loss, such measures can fals...

    Authors: Ling L. Chuah, Alexander D. Miras, Laura M. Perry, Andrew H. Frankel, David J. Towey, Zahraa Al-Mayahi, William Svensson and Carel W. le Roux
    Citation: BMC Nephrology 2018 19:383
  39. Congenital nephrotic syndrome (CNS) is characterised by increased proteinuria, hypoproteinemia, and edema beginning in the first 3 months of life. Recently, molecular genetic studies have identified several ge...

    Authors: Guo-min Li, Qi Cao, Qian Shen, Li Sun, Yi-hui Zhai, Hai-mei Liu, Yu An and Hong Xu
    Citation: BMC Nephrology 2018 19:382
  40. The worldwide prevalence of obesity is increasing. Obesity is associated with a variety of chronic diseases, including chronic kidney disease. Several studies suggested that body mass index (BMI) could be an i...

    Authors: Changwei Wu, Amanda Y. Wang, Guisen Li and Li Wang
    Citation: BMC Nephrology 2018 19:381
  41. Estimated glomerular filtration rate (eGFR) is the clinical standard for assessing kidney function and staging chronic kidney disease. Automated reporting of eGFR using the Modification of Diet in Renal Diseas...

    Authors: Kristine E. Lynch, Ji won Chang, Michael E. Matheny, Alexander Goldfarb, Olga Efimova, Gregorio Coronado and Scott L. DuVall
    Citation: BMC Nephrology 2018 19:380
  42. The prevalence of cognitive disorders in hemodialysis patients is twice as high as the general population, while these disorders often are undiagnosed. Timely prevention and treatment can improve their persona...

    Authors: Afshin Samaei, Monir Nobahar, Zaynab Hydarinia-Naieni, Abbas Ali Ebrahimian, Mohammad Reza Tammadon, Raheb Ghorbani and Abbas Ali Vafaei
    Citation: BMC Nephrology 2018 19:379
  43. Caffeine has been proposed, based on in vitro cultured cell studies, to accelerate progression of autosomal dominant polycystic kidney disease (ADPKD) by increasing kidney size. Since ADPKD patients are advise...

    Authors: Katelyn A. McKenzie, Mirelle El Ters, Vicente E. Torres, Peter C. Harris, Arlene B. Chapman, Michal Mrug, Frederic F. Rahbari-Oskoui, Kyongtae Ty Bae, Douglas P. Landsittel, William M. Bennett, Alan S. L. Yu and Jonathan D. Mahnken
    Citation: BMC Nephrology 2018 19:378
  44. The clinical outcome and health-related quality of life (HRQoL) of living kidney donors is mostly not detrimental, but some donors experience impairment after donation. Gender-specific effects of living kidney...

    Authors: Claudia Sommerer, Sarah Estelmann, Nicole G. Metzendorf, Maren Leuschner and Martin Zeier
    Citation: BMC Nephrology 2018 19:377
  45. To assess the time to first on-study vascular thromboembolic events (VTEs) of clopidogrel (CL) or beraprost sodium (BPS) in Chinese population with end-stage renal disease (ESRD) treated with arteriovenous fis...

    Authors: Yu Zhou, Ling Du, Bo Tu, Qiquan Lai, Xiaonan Du, Bo Xu, Fan Zhang, Mingdong Zhao, Ziming Wan and Jiajie Lai
    Citation: BMC Nephrology 2018 19:376
  46. Following publication of the original article [1], the authors reported an error in the presentation of Table 3 and Table 4.

    Authors: Jutta Dierkes, Helene Dahl, Natasha Lervaag Welland, Kristina Sandnes, Kristin Sæle, Ingegjerd Sekse and Hans-Peter Marti
    Citation: BMC Nephrology 2018 19:375

    The original article was published in BMC Nephrology 2018 19:259

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    2.3 - 2-year Impact Factor
    2.8 - 5-year Impact Factor
    1.064 - SNIP (Source Normalized Impact per Paper)
    0.746 - SJR (SCImago Journal Rank)

    2023 Speed
    28 days submission to first editorial decision for all manuscripts (Median)
    158 days submission to accept (Median)

    2023 Usage 
    3,053,628 downloads
    3,742 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal